| Financial Year |
March 31 2023 |
| Monetary Funds |
3,574,173,045.38 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
150,182,987.58 |
| Accounts Receivable |
2,472,248,358.87 |
| Advances to Suppliers |
734,220,019.17 |
| Other Receivables |
310,077,937.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
2,352,000.00 |
| Inventories |
1,412,429,056.14 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
149,794,429.16 |
| Total Current Assets |
16,104,187,484.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
757,057,947.61 |
| Long-term Equity Investment |
989,752,704.63 |
| Investment Properties |
28,303,034.42 |
| Fixed Assetes |
1,168,389,393.95 |
| Under-construction Projects |
364,911,553.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
342,315,261.74 |
| R&D expenses |
-- |
| Goodwill |
315,312,029.90 |
| Long-Term Deferred and Prepaid Expenses |
30,285,195.17 |
| Deferred Income Tax Assets |
156,048,980.59 |
| Other Non-Current Assets |
98,215,774.87 |
| Sub-Total of Non-Current Assets |
4,752,284,220.77 |
| Total Assets |
20,856,471,705.28 |
| Short-Term Loans |
1,159,191,644.51 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,633,496,714.73 |
| Accounts Payable |
3,864,699,374.96 |
| Accounts Received In Advance |
500,000.00 |
| Employee Compensation Payable |
96,260,979.05 |
| Taxes Payable |
63,518,836.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
280,825,203.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
305,841,666.67 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
10,136,949,377.47 |
| Long-term Loans |
259,839,020.13 |
| Bonds Payable |
1,890,434,991.78 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,612,287.10 |
| Deferred Income Tax Liabilities |
13,335,074.17 |
| Other Non-Current Liabilities |
198,750,000.00 |
| Sub-Total of Non-Current Liabilities |
2,459,549,258.99 |
| Total Liabilities |
12,596,498,636.46 |
| Paid-In Capital(Or Share Stock) |
2,012,882,195.00 |
| Capital Surplus |
1,691,915,541.96 |
| Surplus Reserve |
243,138,672.78 |
| LESS:Treasury Stock |
99,999,606.81 |
| Undistributed Profits |
4,169,629,137.60 |
| Minority Stockholder's Interest |
31,975,084.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,227,997,984.51 |
| Owner's Equity（Stockholder's Equity） |
8,259,973,068.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,856,471,705.28 |
